ETX.L - e-Therapeutics plc
LSE - LSE Delayed price. Currency in GBp
8.25
+0.07 (+0.92%)
At close: 4:30PM BST
Stock chart is not supported by your current browser
| Previous close | 8.18 |
| Open | 8.28 |
| Bid | 8.10 x 0 |
| Ask | 8.40 x 0 |
| Day's range | 7.95 - 8.46 |
| 52-week range | 1.25 - 8.98 |
| Volume | 801,688 |
| Avg. volume | 1,326,717 |
| Market cap | 26.6M |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.90 |
| Earnings date | 17 Mar 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.00 |
- Simply Wall St.
Investors Who Bought e-Therapeutics (LON:ETX) Shares Five Years Ago Are Now Down 88%
While it may not be enough for some shareholders, we think it is good to see the e-Therapeutics plc (LON:ETX) share...
- Reuters - UK Focus
Suspended Woodford fund has sold around 100 mln pounds of assets
Neil Woodford has sold 97 million pounds ($123 million) of shares over the past 10 days to boost liquidity in his suspended equity income fund, a Woodford spokesman said on Thursday. Market participants have been expecting a wave of forced selling by Woodford, with some hedge funds taking out short positions against his investments. "Since suspension, Woodford has sold 97.1 million pounds of stock as he continues to reposition the Woodford Equity Income Fund portfolio," a Woodford spokesman said by email.
